Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

Healthcare Biotechnology
iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Satellos Bioscience Inc Com > Quietly
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by viktorskateon Jun 29, 2018 10:15am
90 Views
Post# 28250737

RE:RE:Quietly

RE:RE:QuietlyI am with you GreenHawk. The company has really great structure and truly cares about this, and they have everything that it takes to make it happen.  Let's be honest, the news release 2 days ago really shows how the study is going, and once the real results come out, all of believe that they will be better than expected, and just from that, it will take us closer to the half dollar mark. Realistically speaking, the company has the potential to be in the $1.50 range by year end , just look at the potential !! HOLDING STRONG ! GREAT DAYS AHEAD !!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities